肾内科医生应了解的孟德尔随机化方法
本文综述了孟德尔随机化(MR)的基本概念、在肾内科的应用与相关性、方法学挑战与局限性及现有设计与报告指南。以估算肾小球滤过率与癌症因果关系的临床相关实例,概述了开展MR研究的关键步骤及每一步的考虑与潜在陷阱。
要点
- MR利用遗传变异作为工具变量,在观察性数据中检验暴露对结局的因果效应。
- 肾内科大规模全基因组关联研究的出现使MR成为建立因果推断的流行方法。
- 开展MR需仔细考虑连锁不平衡、工具变量强度、数据协调及结果解释等步骤。
核心结论
- MR是检验因果效应的有力研究设计,但方法复杂且具挑战性,需仔细考虑以确保结果稳健。
研究设计与样本
- 综述文章,旨在总结MR基本概念、在肾内科的应用与相关性、方法学挑战与局限性及当前设计与报告指南。
主要发现
- 以估算肾小球滤过率与癌症因果关系的临床相关实例,概述了开展MR研究的关键步骤及每一步的关键考虑与潜在陷阱。
关键数值与推荐
- 关键步骤包括:定义临床问题、选择数据来源、考虑连锁不平衡及与潜在混杂因素的关联来识别和精炼遗传变异、跨数据集协调变异、通过评估工具强度验证遗传工具、估计因果效应、确认发现有效性、解释和报告结果。
临床怎么用
- 肾内科医生可参考本文所述MR研究的关键步骤与考虑因素,以理解和评价基于MR的因果推断研究。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Confounding is a major limitation of observational studies. Mendelian randomization (MR) is a powerful study design that uses genetic variants as instrumental variables to enable examination of the causal effect of an exposure on an outcome in observational data. With the emergence of large-scale genome-wide association studies in nephrology over the past decade, MR has become a popular method to establish causal inferences. However, MR is a complex and challenging methodology that requires careful consideration to ensure robust results. This review article aims to summarize the basic concepts of MR, its application and relevance in nephrology, and the methodological challenges and limitations as well as discuss the current guidelines for design and reporting. With reference to a clinically relevant example of examining the causal relationship between the estimated glomerular filtration rate and cancer, this review outlines the key steps to conducting an MR study, including the key considerations and potential pitfalls at each step. These include defining the clinical question, selecting the data sources, identifying and refining appropriate genetic variants by considering linkage disequilibrium and associations with potential confounders, harmonization of variants across data sets, validation of the genetic instrument by assessing its strength, estimation of the causal effects, confirming the validity of the findings, and interpreting and reporting results.
引用
- Dobrijevic E, van Zwieten A, Kiryluk K, et al. Mendelian randomization for nephrologists. Kidney Int. 2023. PMID: 37783446. doi:10.1016/j.kint.2023.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。